RECRUITING
I'm interested ...!!
EHR-integrated rUTI Texting Platform
The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI). The main question it aims to answer is: • can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics for recurrent UTIs as compared to usual care? Participants enrolled onto the texting platform will: • receive evidence-based clinical guidance for the management of symptoms of UTI and receive educational videos on how to prevent UTIs. An important secondary outcome is to determine if the texting platform improves self-efficacy for the management of recurrent UTI.
Conditions:
🦠 Recurrent Urinary Tract Infection
🗓️ Study Start (Actual) 7 March 2024
🗓️ Primary Completion (Estimated) 15 June 2025
✅ Study Completion (Estimated) 15 June 2026
👥 Enrollment (Estimated) 100
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Philadelphia, Pennsylvania, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Provision of signed and dated informed consent form
    • 2. Stated willingness to comply with all study procedures and availability for the duration of the study
    • 3. Females who currently meet the criteria for recurrent UTIs
    • 4. Age 18 years or older
    • 5. Owns a mobile device with text messaging capability
    • 6. Ability to read and write English
    • 7. Currently receiving care from a provider in Penn Urogynecology or Penn Urology

    Exclusion Criteria:

    • 1. History of known multidrug resistant UTIs
    • 2. History of interstitial cystitis/bladder pain syndrome or current diagnosis of chronic pelvic pain
    • 3. On continuous suppressive antibiotics currently
    • 4. Currently pregnant or within 6 weeks of pregnancy
    • 5. Transplant patient on immunosuppressive medication currently
    • 6. Practice of chronic self-catheterization
Ages Eligible for Study: 18 Years to 100 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 6 September 2023
  • First Submitted that Met QC Criteria 6 September 2023
  • First Posted 13 September 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 15 March 2024
  • Last Update Posted 19 March 2024
  • Last Verified March 2024
I'm interested ...!!